BREVILLE GROUP LIMITED (BRG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BRG

BRG - BREVILLE GROUP LIMITED

Year End: June
GICS Industry Group : Retailing
Debt/EBITDA: 0.64
Index: ASX200 | ASX300 | ALL-ORDS

Breville is an Australian multinational manufacturer of kitchen products and small electrical appliances. Established in 1932, it became a listed company in 1999.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$31.91

26 Mar
2025

-0.090

OPEN

$32.45

-0.28%

HIGH

$32.45

263,999

LOW

$31.27

TARGET
$38.358 20.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ABY . AOV . DSK . MYR . SSG . TRS .
FNARENA'S MARKET CONSENSUS FORECASTS
BRG: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 82.7 92.8 xxx
DPS (cps) xxx 33.0 37.0 xxx
EPS Growth xxx 7.1% 12.2% xxx
DPS Growth xxx 8.2% 12.1% xxx
PE Ratio xxx N/A 33.7 xxx
Dividend Yield xxx N/A 1.2% xxx
Div Pay Ratio(%) xxx 39.9% 39.9% xxx

Dividend yield today if purchased 3 years ago: 1.17%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.05

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 12/09 - ex-div 17c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx82.7
DPS All xxxxxxxxxxxxxxx33.0
Sales/Revenue xxxxxxxxxxxxxxx1,530.0 M
Book Value Per Share xxxxxxxxxxxxxxx591.4
Net Operating Cash Flow xxxxxxxxxxxxxxx302.6 M
Net Profit Margin xxxxxxxxxxxxxxx7.75 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx14.65 %
Return on Invested Capital xxxxxxxxxxxxxxx11.81 %
Return on Assets xxxxxxxxxxxxxxx8.73 %
Return on Equity xxxxxxxxxxxxxxx14.65 %
Return on Total Capital xxxxxxxxxxxxxxx17.88 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx232.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx25 M
Long Term Debt xxxxxxxxxxxxxxx131 M
Total Debt xxxxxxxxxxxxxxx156 M
Goodwill - Gross xxxxxxxxxxxxxxx324 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx138 M
Price To Book Value xxxxxxxxxxxxxxx4.59

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx62.1 M
Capex % of Sales xxxxxxxxxxxxxxx4.06 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,229 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx117 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx4 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

12/02/2025

3

Neutral

$37.40

17.20%

UBS considers the key news from Breville Group's 1H result was the expansion of direct distribution into the Middle East (since January) and China in the current half.

While the broker sees growth potential, it maintains a Neutral rating, noting the stock is trading at a multiple last seen during covid, when sales were growing at approximately 25%.

Sales momentum was solid globally in H1, and category demand outside coffee, particularly in food preparation and cooking, is improving, observe the analysts.

Management’s FY25 earnings (EBIT) guidance for 5-10% growth appears conservative to UBS.

Neutral maintained. Target rises to $37.40 from $32.70.

FORECAST
UBS forecasts a full year FY25 dividend of 36.00 cents and EPS of 92.00 cents.
UBS forecasts a full year FY26 dividend of 41.00 cents and EPS of 105.00 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

3

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Petra Capital

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

13/02/2025

3

Neutral

$32.60

2.16%

Jarden believes Breville's 1H25 result was a material event, with the company de-risking earnings for the next three years and expanding in the second-biggest global economy. The broker sees risk to consensus sales remaining skewed on the upside

The result was a small beat vs consensus, and management guided to 5-10% EBIT growth in FY25, implying a downgrade to consensus of -10% at the mid-point. 

The broker lowered its forecasts to the top of the EBIT guidance range, noting among other things, the forecast for deceleration in 2H25 Americas growth to 6% is conservative. 

The broker's DCF-based valuation lifts substantially to reflect China in the longer-term forecasts, with higher EBITDA and terminal growth up by 50bp. Target price rises to $32.6 from $26.3. Neutral maintained.

FORECAST
Jarden forecasts a full year FY25 dividend of 37.00 cents and EPS of 94.40 cents.
Jarden forecasts a full year FY26 dividend of 41.00 cents and EPS of 105.40 cents.

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

BRG STOCK CHART